The content on this site is intended for healthcare professionals only
Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year...
Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA
10 May 2022
Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for rese...
Prof Nicolas Girard - Institut Curie, Paris, France
10 May 2022
Recent advances in the treatment of patients with exon 20 insertion-positive NSC...
Dr Alfredo Addeo, Prof Nicolas Girard and Prof Natasha Leighl
21 Apr 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy...
Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madr...
31 Mar 2022
Real-world increase in biomarker testing in lung cancer
Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda,...
30 Mar 2022
EGFR testing: Best practice for NSCLC patients with exon 20 insertions
Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari
30 Mar 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Feb 2022
Lung cancer in India
Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
3 Feb 2022
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla...
19 Jan 2022
OncoAlert Colloquium Day 2: Lung cancer and MASCC
Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee, ...
19 Jan 2022
Latest in diagnostics in EGFR mutated NSCLC
Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA
3 Dec 2021